Tranzactioneaza Madrigal Pharmaceuticals (US.MDGL) - 498.62 USD (%) Tranzactioneaza
1D
1W
1M
3M
6M
1Y
5Y
Max
Indici
Descriere companie
Madrigal Pharmaceuticals, Inc. (http://www.madrigalpharma.com) is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.